Probing HLA-B7 Conformational Shifts Induced by Peptide-Binding Groove Mutations and Bound Peptide with Anti-HLA Monoclonal Antibodies

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2470-2478

  Smith, Kelly D ^a   Mace, Brian E ^a   Valenzuela, Alicia ^a   Vigna, Janet L ^a   McCutcheon, Jane A ^a,d   Barbosa, James A ^b   Huczko, Eric ^c   Engelhard, Victor H ^c   Lutz, Charles T ^a  

^a UNIVERSITY OF IOWA   (United States)

^b BAYER CORPORATION   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA B7 ANTIGEN; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT;

ARTICLE; BINDING COMPETITION; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING;

ANTIBODIES, MONOCLONAL; BINDING, COMPETITIVE; CELL LINE; EPITOPES; HLA-B7 ANTIGEN; HUMANS; MUTATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 0030587082     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Huczko, E. L., W. M. Bodnar, D. Benjamin, K. Sakaguchi, N. Z. Zhu, J. Shabanowitz, R. A. Henderson, E. Appella, D. F. Hunt, and V. H. Engelhard. 1993. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J. Immunol. 151:2572.
2. b. Science 257:919.
3. Silver, M. L., H.-C. Guo, J. L. Strominger, and D. C. Wiley. 1992. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 360:367.
4. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
5. b at 2.4 Å resolution: implications for antigen-determinant selection. Cell 76:39.
6. Davies, D. R., E. A. Padlan, and S. Sheriff. 1990. Antibody-antigen complexes. Annu. Rev. Biochem. 59:439.
7. Bentley, G. A., G. Boulot, K. Karjalainen, and R. A. Mariuzza. 1995. Crystal structure of the β chain of a T cell antigen receptor. Science 267:1984.
8. Fields, B. A., B. Ober, E. L. Malchiodi, M. I. Lebedeva, B. C. Bradford, X. Ysern, J.-K. Kim, S. Xuguang, E. S. Ward, and R. A. Mariuzza. 1995. Crystal structure of the Vα domain of a T cell receptor. Science 270:1821.
9. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92:2479.
10. Smith, K. J., S. W. Reid, K. Harlos, A. J. McMichael, D. I. Stuart, J. I. Bell, and K. Y. Jones. 1996. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4:215.
11. Bluestone, J. A., S. Jameson, S. Miller, and R. Dick, II. 1992. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176:1757.
12. Catipovic, B., J. Dal Porto, M. Mage, T. E. Johansen, and J. P. Schneck. 1992. Major histocompatibility complex conformational epitopes are peptide specific. J. Exp. Med. 176:1611.
13. b using a monoclonal antibody. Biochem. Biophys. Res. Commun. 186:1449.
14. Bluestone, J. A., A. Kaliyaperumal, S. Jameson, S. Miller, and R. Dick II. 1993. Peptide-induced conformational changes in class I heavy chains alters allorecognition. J. Immunol. 151:3943.
15. Hogquist, K. A., A. G. Grandea III, and M. J. Bevan. 1993. Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur. J. Immunol. 23:3028.
16. Sherman, L. A., S. Chattopadhyay, J. A. Biggs, R. F. Dick, II, and J. A. Bluestone. 1993. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc. Natl. Acad. Sci. USA 90:6949.
17. Nathenson, S. G., J. Geliebter, G. M. Pfaffenbach, and R. A. Zeff. 1986. Murine major histocompatibility complex class-I mutants: molecular analysis and structure-function implications. Annu. Rev. Immunol. 4:471.
18. Ajitkumar, P., S. S. Geier, K. V. Kesari, F. Borriello, M. Nakagawa, J. A. Bluestone, M. A. Saper, D. C. Wiley, and S. G. Nathenson. 1988. Evidence that multiple residues on both the α-helices of the class I MHC molecule are simutaneously recognized by the T cell receptor. Cell 54:47.
19. d serologic recognition. J. Immunol. 151:5387.
20. Collawn, J. F., C. J. A. Wallace, A. E. I. Proudfoot, and Y. Paterson. 1988. Monoclonal antibodies as probes of conformational changes in protein-engineered cytochrome c. J. Biol. Chem. 263:8625.
21. Cunningham, B. C., P. Jhurani, P. Ng, and J. A. Wells. 1989. Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science 243:1330.
22. Kurago, Z. B., K. D. Smith, and C. T. Lutz. 1995. Natural killer cell recognition of MHC class I: NK cells are sensitive to peptide binding groove and surface α-helical mutations that affect T cells. J. Immunol. 154:2631.
23. Parham, P., P. Antonelli, L. A. Herzenberg, T. J. Kipps, A. Fuller, and F. E. Ward. 1986. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum. Immunol. 15:44.
24. Trapani, J. A., S. Mizuno, S. H. Kang, S. Y. Yang, and B. Dupont. 1989. Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody. Immunogenetics 29:25.
25. Mizuno, S., S. H. Kang, H. W. Lee, J. A. Trapani, B. Dupont, and S. Y. Yang. 1989. Isolation and expression of a cDNA clone encoding HLA-Cw6: unique characteristics of HLA-C encoded gene products. Immunogenetics 29:323.
26. Smith, K. D., A. Valenzuela, J. L. Vigna, K. Aalbers, and C. T. Lutz. 1993. Unwanted mutations in PCR mutagenesis: avoiding the predictable. PCR Methods Appl. 2:253.
27. McCutcheon, J. A., and C. T. Lutz. 1992. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Hum. Immunol. 35:125.
28. 27a. McCutcheon, J. A., K. D. Smith, A. Valenzuela, K. Aalbers, and C. T. Lutz. 1993. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues. Hum. Immunol. 36:69.
29. Barbosa, J. A., J. Santos-Aguado, S. J. Mentzer, J. L. Strominger, S. J. Burakoff, and P. A. Biro. 1987. Site-directed mutagenesis of class I HLA genes: role of glycosylation in surface expression and functional recognition. J. Exp. Med. 166: 1329.
30. Smith, K. D., D. F. Epperson, and C. T. Lutz. 1995. Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation. Immunogenetics 43:27.
31. Engelhard, V. H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol 6:13.
32. Zeh, H. J., III, G. H. Leder, M. T. Lotze, R. D. Salter, M. Tector, G. Stuber, S. Modrow, and W. J. Storkus. 1994. Flow-cytometric determination of peptide-class I complex formation: identification of p53 peptides that bind to HLA-A2. Hum. Immunol. 39:79.
33. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506.
34. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219:277.
35. Wells, J. A. 1990. Additivity of mutational effects in proteins. Biochemistry 29: 8509.
36. Hill, A., A. Worth, T. Elliott, S. Rowland-Jones, J. Brooks, A. Rickinson, and A. McMichael. 1995. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7. Eur. J. Immunol. 25:18.
37. Maier, R., K. Falk, O. Rötzschke, B. Maier, V. Gnau, S. Stevanovic, G. Jung, H.-G. Rammensee, and A. Meyerhans. 1994. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40:306.
38. Collins, E. J., D. N. Garboczi, and D. C. Wiley. 1994. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371:626.
39. Benjamin, D. C., J. A. Berzofsky, I. J. East, F. R. N. Gurd, C. Hannum, S. J. Leach, E. Margoliash, J. G. Michael, A. Miller, E. M. Prager, M. Reichlin, E. E. Sercarz, S. J. Smith-Gill, P. E. Todd, and A. C. Wilson. 1984. The antigenic structure of proteins: a reappraisal. Annu. Rev. Immunol. 2:67.
40. Jin, L., B. M. Fendly, and J. A. Wells. 1992. High resolution functional analysis of antibody-antigen interactions. J. Mol. Biol. 226:851.
41. Novotny, J., R. E. Bruccoleri, and F. A. Saul. 1989. On the attribution of binding energy in antigen-antibody complexes McPC 603, D1.3 and HyHEL-5. Biochemistry 28:4735.
42. Hawkins, R. E., S. J. Russell, M. Baier, and G. Winter. 1993. The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen: the interaction of mutant D1.3 antibodies with lysozyme. J. Mol. Biol. 234:958.
43. Kelley, R. F. and M. P. O'Connell. 1993. Thermodynamic analysis of an antibody functional epitope. Biochemistry 32:6828.
44. Nuss, J. M., P. B. Whitaker, and G. M. Air. 1993. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase. Proteins 15:121.
45. Jin, L. and J. A. Wells. 1994. Dissecting the energetics of an antibody-antigen interface by alanine shaving and molecular grafting. Protein Sci. 3:2351.
46. Zemmour, J., and P. Parham. 1991. HLA class I nucleotide sequences. 1991. Hum. Immunol. 31:195.
47. Toubert, A., C. Raffoux, J. Boretto, J. Sire, R. Sodoyer, S. R. Thurau, B. Amor, J. Colobani, F. A. Lemonnier, and B. R. Jordan. 1988. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants. J. Immunol. 141: 2503.
48. Wang, J., D. T. Y. Yu, T. Fukazawa, H. Kellner, J. Wen, X.-K. Cheng, G. Roth, K. M. Williams, and R. B. Raybourne. 1994. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J. Immunol. 152:1197.
49. Eigenbrot, C., M. Randal, and A. A. Kossiakoff. 1992. Structural effects induced by mutagenesis affected by crystal packing factors: the structure of a 30-51 disulfide mutant of basic pancreatic trypsin inhibitor. Proteins 14:75.
50. Lutz, C. T., K. D. Smith, N. S. Greazel, B. E. Mace, D. A. Jensen, J. A. McCutcheon, and N. E. Goeken. 1994. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the α-1 helix. J. Immunol. 153:4099.
51. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70:1035.